SCMP Financial Facts

Interest expense: -6.27M
General and administrative: 8.93M
See Full Income Statement

Deferred revenue, non-current: 941K
Additional paid-in capital: 102.12M
See Full Balance Sheet

Sucampo Pharmaceuticals (SCMP) Earnings

  |   Expand Research on SCMP
Next EPS Date 8/3/16 EPS Growth Rate +4.8%
Average EPS % Beat Rate +41.4% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS -2.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/3/16 Q216 N/A$0.22 N/A N/A$48.33M = N/A N/A
5/4/16 Q116 $0.21$0.19 +$0.02$47.2M$44.11M = Details
3/8/16 Q415 $0.43$0.19 +$0.24$55.4M$42.72M = Details
11/4/15 Q315 $0.16$0.18 -$0.02$33.5M$36.18M = Details
8/5/15 Q215 $0.21$0.15 +$0.06$34.9M$31.9M = Details
5/6/15 Q115 $0.14$0.12 +$0.02$29.5M$30.19M = Details
3/4/15 Q413 $0.21$0.18 +$0.03$37.8M$37.23M = Details
11/6/14 Q313 $0.03$0.04 -$0.01$31.5M$26.11M N/A Details